首页> 外文期刊>The journal of clinical endocrinology and metabolism >Familial Glucocorticoid Resistance Caused by a Novel Frameshift Glucocorticoid Receptor Mutation
【24h】

Familial Glucocorticoid Resistance Caused by a Novel Frameshift Glucocorticoid Receptor Mutation

机译:由新型葡萄糖糖皮质激素受体突变引起的家族性糖皮质激素

获取原文
       

摘要

Context: Familial glucocorticoid resistance is a rare condition with a typical presentation of women with hirsutism and hypertension, with or without hypokalemia.Objective: The aim was to determine the cause of apparent glucocorticoid resistance in a young woman.Patients and Methods: We studied a family with a novel glucocorticoid receptor (GR) mutation and a surprisingly mild phenotype. Their discovery resulted from serendipitous measurement of serum cortisol with little biochemical or clinical evidence for either hyperandrogenism or mineralocorticoid excess.Results: The causative mutation was identified as a frameshift mutation in exon 6. Transformed peripheral blood lymphocytes were generated to analyze GR expression in vitro . Carriers of the mutation had less full-length GR, but the predicted mutant GR protein was not detected. However, this does not exclude expression in vivo , and so the mutant GR (Δ612GR) was expressed in vitro . Simple reporter gene assays suggested that Δ612GR has dominant negative activity. Δ612GR was not subject to ligand-dependent Ser~(211) phosphorylation or to ligand-dependent degradation. A fluorophore-tagged construct showed that Δ612GR did not translocate to the nucleus in response to ligand and retarded translocation of the wild-type GR. These data suggest that Δ612GR is not capable of binding ligand and exerts dominant negative activity through heterodimerization with wild-type GR.Conclusion: Therefore, we describe a novel, naturally occurring GR mutation that results in familial glucocorticoid resistance. The mutant GR protein, if expressed in vivo , is predicted to exert dominant negative activity by impairing wild-type GR nuclear translocation.
机译:背景信息:家族性糖皮质激素是一种罕见的病情,具有典型的妇女伴随着血红音和高血压,有或没有低血压症。目的是确定年轻女性中表观糖皮质激素抗性的原因.Patient和方法:我们研究了家族用新型糖皮质激素受体(GR)突变和令人惊讶的轻度表型。它们的发现是由血清皮质醇的偶然测量产生的生物化学或临床证据少于高萌发性或矿物质皮质过量。结果:致病性突变被鉴定为外显子6中的框架突变。产生转化的外周血淋巴细胞以分析体外的GR表达。突变的载体具有较少的全长GR,但未检测到预测的突变GR蛋白。然而,这并不排除体内表达,因此突变遗传仪GR(Δ612GR)在体外表达。简单的报告基因测定表明Δ612GR具有显性负活性。 Δ612GR不受配体依赖性的Ser〜(211)磷酸化或配体依赖性降解的约束。荧光团标记构建体表明Δ612gR响应于配体并延迟易于易于野生型GR的易位而没有夸核。这些数据表明Δ612GR能够结合配体,并通过用野生型GR的异二聚化施加显性阴性活性。因此,我们描述了一种新的天然存在的GR突变,导致家族性糖皮质激素抗性。如果在体内表达,突变族族族族族族族族族族族族族族族族族族族族族族族族族族族族族族族族族族族将通过损害野生型GR核易位而发挥显性负活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号